Found: 22
Select item for more details and to access through your institution.
Striatal delta opioid receptor binding in experimental models of Parkinson's disease and dyskinesia.
- Published in:
- 2007
- By:
- Publication type:
- journal article
Loss of Lipid Carrier ApoE Exacerbates Brain Glial and Inflammatory Responses after Lysosomal GBA1 Inhibition.
- Published in:
- Cells (2073-4409), 2023, v. 12, n. 21, p. 2564, doi. 10.3390/cells12212564
- By:
- Publication type:
- Article
The Toll-Like Receptor-3 Agonist Polyinosinic:Polycytidylic Acid Triggers Nigrostriatal Dopaminergic Degeneration.
- Published in:
- Journal of Neuroscience, 2010, v. 30, n. 48, p. 16091, doi. 10.1523/JNEUROSCI.2400-10.2010
- By:
- Publication type:
- Article
PSD-95 Uncouples Dopamine-Glutamate Interaction in the D<sub>1</sub>/PSD-95/NMDA Receptor Complex.
- Published in:
- Journal of Neuroscience, 2009, v. 29, n. 9, p. 2948, doi. 10.1523/JNEUROSCI.4424-08.2009
- By:
- Publication type:
- Article
Striatal histone modifications in models of levodopa-induced dyskinesia.
- Published in:
- Journal of Neurochemistry, 2008, v. 106, n. 1, p. 486, doi. 10.1111/j.1471-4159.2008.05417.x
- By:
- Publication type:
- Article
Progressive axonal transport and synaptic protein changes correlate with behavioral and neuropathological abnormalities in the heterozygous Q175 KI mouse model of Huntington's disease.
- Published in:
- Human Molecular Genetics, 2014, v. 23, n. 17, p. 4510, doi. 10.1093/hmg/ddu166
- By:
- Publication type:
- Article
Fibroblasts from idiopathic Parkinson's disease exhibit deficiency of lysosomal glucocerebrosidase activity associated with reduced levels of the trafficking receptor LIMP2.
- Published in:
- Molecular Brain, 2021, v. 14, n. 1, p. 1, doi. 10.1186/s13041-020-00712-3
- By:
- Publication type:
- Article
Upregulating β-hexosaminidase activity in rodents prevents α-synuclein lipid associations and protects dopaminergic neurons from α-synuclein-mediated neurotoxicity.
- Published in:
- Acta Neuropathologica Communications, 2020, v. 8, n. 1, p. 1, doi. 10.1186/s40478-020-01004-6
- By:
- Publication type:
- Article
Novel Results and Concepts Emerging From Lipid Cell Biology Relevant to Degenerative Brain Aging and Disease.
- Published in:
- Frontiers in Neurology, 2019, p. 1, doi. 10.3389/fneur.2019.01053
- By:
- Publication type:
- Article
Glycosphingolipid metabolism and its role in ageing and Parkinson's disease.
- Published in:
- Glycoconjugate Journal, 2022, v. 39, n. 1, p. 39, doi. 10.1007/s10719-021-10023-x
- By:
- Publication type:
- Article
Correction to: Reduced sphingolipid hydrolase activities, substrate accumulation and ganglioside decline in Parkinson's disease.
- Published in:
- 2020
- By:
- Publication type:
- Correction Notice
Reduced sphingolipid hydrolase activities, substrate accumulation and ganglioside decline in Parkinson's disease.
- Published in:
- Molecular Neurodegeneration, 2019, v. 14, n. 1, p. N.PAG, doi. 10.1186/s13024-019-0339-z
- By:
- Publication type:
- Article
Dopamine D<sub>1</sub> Activation Potentiates Striatal NMDA Receptors by Tyrosine Phosphorylation-Dependent Subunit Trafficking.
- Published in:
- Journal of Neuroscience, 2006, v. 26, n. 17, p. 4690, doi. 10.1523/JNEUROSCI.0792-06.2006
- By:
- Publication type:
- Article
Synaptic recruitment of AMPA glutamate receptor subunits in levodopa-induced dyskinesia in the MPTP-lesioned nonhuman primate.
- Published in:
- Synapse, 2010, v. 64, n. 2, p. 177, doi. 10.1002/syn.20739
- By:
- Publication type:
- Article
Acid ceramidase involved in pathogenic cascade leading to accumulation of α-synuclein in iPSC model of GBA1-associated Parkinson's disease.
- Published in:
- Human Molecular Genetics, 2023, v. 32, n. 11, p. 1888, doi. 10.1093/hmg/ddad025
- By:
- Publication type:
- Article
Mitochondrial clearance and maturation of autophagosomes are compromised in LRRK2 G2019S familial Parkinson's disease patient fibroblasts.
- Published in:
- Human Molecular Genetics, 2019, v. 28, n. 19, p. 3232, doi. 10.1093/hmg/ddz126
- By:
- Publication type:
- Article
Lipid and immune abnormalities causing age-dependent neurodegeneration and Parkinson's disease.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Viral-like TLR3 induction of cytokine networks and α-synuclein are reduced by complement C3 blockade in mouse brain.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-41240-z
- By:
- Publication type:
- Article
Viral-like TLR3 induction of cytokine networks and α-synuclein are reduced by complement C3 blockade in mouse brain.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-41240-z
- By:
- Publication type:
- Article
A Nurr1 Agonist Causes Neuroprotection in a Parkinson’s Disease Lesion Model Primed with the Toll-Like Receptor 3 dsRNA Inflammatory Stimulant Poly(I:C).
- Published in:
- PLoS ONE, 2015, v. 10, n. 3, p. 1, doi. 10.1371/journal.pone.0121072
- By:
- Publication type:
- Article
Advantages and Recent Developments of Autologous Cell Therapy for Parkinson's Disease Patients.
- Published in:
- Frontiers in Cellular Neuroscience, 2020, p. 1, doi. 10.3389/fncel.2020.00058
- By:
- Publication type:
- Article
Loss of apolipoprotein E exacerbates microglial and astrocyte reactivity to sustained systemic glucocerebrosidase inhibition.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.066226
- By:
- Publication type:
- Article